ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nevada » Neurology

Top Neurology Prescribers in Nevada

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GREGORY BAKER DO

Neurology

1,163

$120K

217
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 24%

$104
Average prescription price

Avg: $272

DAVID DAPRA MD

Neurology

1,148

$195K

132
82 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

11%
prescriptions for brand name drugs

Avg: 24%

$170
Average prescription price

Avg: $272

BESS CHANG D.O.

Neurology

1,139

$525K

202
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 24%

$461
Average prescription price

Avg: $272

JONATHAN SPIVACK MD

Neurology

1,131

$170K

136
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 24%

$151
Average prescription price

Avg: $272

GABRIEL LEGER MD CM

Neurology

1,114

$143K

167
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

54%
prescriptions for brand name drugs

Avg: 24%

$128
Average prescription price

Avg: $272

SYED ALI MEDICAL DOCTOR

Neurology

1,035

$92.3K

145
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$89
Average prescription price

Avg: $272

SIMON FARROW MD

Neurology

1,035

$148K

141
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $272

CHRISTOPHER MILFORD MD

Neurology

1,002

$177K

193
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$176
Average prescription price

Avg: $272

LEO GERMIN MD

Neurology

995

$1.31M

178
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 24%

$1319
Average prescription price

Avg: $272

LISA COHEN M.D.

Neurology

975

$169K

135
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 24%

$173
Average prescription price

Avg: $272

JOHN PEACOCK MD, PHD

Neurology

893

$147K

83
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$164
Average prescription price

Avg: $272

CHARLES QUAGLIERI M.D.

Neurology

826

$630K

105
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 24%

$762
Average prescription price

Avg: $272

EDGAR JAY EVANGELISTA MD

Neurology

787

$458K

127
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 24%

$582
Average prescription price

Avg: $272

MALCOLM BACCHUS M.D.

Neurology

780

$264K

96
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 24%

$339
Average prescription price

Avg: $272

GERARD HERSHEWE DO

Neurology

740

$46K

137
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $272

NIDHI MEHTA MD

Neurology

713

$105K

97
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 24%

$147
Average prescription price

Avg: $272

GERALD DUNN MD

Neurology

678

$114K

94
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

10%
prescriptions for brand name drugs

Avg: 24%

$168
Average prescription price

Avg: $272

JIMMY JOHN NOVERO M.D.

Neurology

616

$266K

112
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 24%

$433
Average prescription price

Avg: $272

TIMOTHY WEST MD

Neurology

564

$789K

93
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 24%

$1400
Average prescription price

Avg: $272

MIRACLE WANGSUWANA D.O.

Neurology

551

$383K

87
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

30%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$696
Average prescription price

Avg: $272

DOBRIN DOBREV MD

Neurology

422

$31K

121
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $272

ABRAHAM NAGY M.D.

Neurology

334

$20.4K

48
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

9%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $272

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank